Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Female. Found 907 abstracts

no pagination
Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS, Turpin B, Dowlati A, Brose MS, Mascarenhas L, Federman N, Berlin J, El-Deiry WS, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski ER, Meric-Bernstam F, Sohal DP, Ma PC, Raez LE, Hechtman JF, Benayed R, Ladanyi M, Tuch BB, Ebata K, Cruickshank S, Ku NC, Cox MC, Hawkins DS, Hong DS, Hyman DM. Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. The New England journal of medicine. 2018 Feb 22;378(8):731-9.   PMCID: PMC5857389
Handra-Luca A, Wei S. Intrathyroid cystic thyroglossal duct remnant and ectopic thymus: a fortuitous or development-related association?. Surgery today. 2018 Aug;48(8):815-8.
Lamb EP, Pritchard FE, Nouer SS, Tolley EA, Boyd BS, Davidson JT, Munene G, Fleming MD. Understanding Disparities in Breast Cancer Care in Memphis, Tennessee. Am Surg. 2018 May;84(5):620-7.
Lee MH, Chakhtoura M, Sriram U, Caricchio R, Gallucci S. Conventional DCs from Male and Female Lupus-Prone B6.NZM Sle1/Sle2/Sle3 Mice Express an IFN Signature and Have a Higher Immunometabolism That Are Enhanced by Estrogen. Journal of immunology research. 2018 Apr;2018:1601079.   PMCID: PMC5925037
Manley C, Olszanski A. Melanoma in the Bronchus. The New England journal of medicine. 2018 Nov 15;379(20):e36.
Schwartz LA, Henry-Moss D, Egleston B, Patrick-Miller L, Markman E, Daly M, Tuchman L, Moore C, Rauch PK, Karpink K, Sands CB, Domchek SM, Bradbury AR. Preventative Health and Risk Behaviors Among Adolescent Girls With and Without Family Histories of Breast Cancer. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 2018 Oct 06;.
Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Am J Clin Oncol. 2018 Jan;41(1):59-64.   PMCID: PMC4769977
Arthur DW, Winter KA, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White J. NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. Int J Radiat Oncol Biol Phys. 2017 Aug;98(5):1028-35.   PMCID: PMC5572128
Bhimla A, Yap L, Lee M, Seals B, Aczon H, Ma GX. Addressing the Health Needs of High-Risk Filipino Americans in the Greater Philadelphia Region. J Community Health. 2017 Apr;42(2):269-77.   PMCID: PMC5337442
Bodson J, Ding Q, Warner EL, Hawkins AJ, Henry KA, Kepka D. Sub-Regional Assessment of HPV Vaccination Among Female Adolescents in the Intermountain West and Implications for Intervention Opportunities. Matern Child Health J. 2017 Jul;21(7):1500-11.
Bodson J, Ding Q, Warner EL, Hawkins AJ, Henry KA, Kepka D. Sub-Regional Assessment of HPV Vaccination Among Female Adolescents in the Intermountain West and Implications for Intervention Opportunities. Matern Child Health J. 2017 Jan 13;.
Chakhtoura M, Sriram U, Heayn M, Wonsidler J, Doyle C, Dinnall JA, Gallucci S, Roberts RA. Bisphenol A Does Not Mimic Estrogen in the Promotion of the In Vitro Response of Murine Dendritic Cells to Toll-Like Receptor Ligands. Mediators of inflammation. 2017 Jan;2017:2034348.   PMCID: PMC5547709
Choueiri TK, Plimack E, Arkenau HT, Jonasch E, Heng DY, Powles T, Frigault MM, Clark EA, Handzel AA, Gardner H, Morgan S, Albiges L, Pal SK. Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer. J Clin Oncol. 2017 Sep 10;35(26):2993-3001.
Churilla TM, Egleston B, Bleicher R, Dong Y, Meyer J, Anderson P. Disparities in the Local Management of Breast Cancer in the US according to Health Insurance Status. Breast J. 2017 Mar;23(2):169-76.
Coleman RL, Brady MF, Herzog TJ, Sabbatini P, Armstrong DK, Walker JL, Kim BG, Fujiwara K, Tewari KS, O'Malley DM, Davidson SA, Rubin SC, DiSilvestro P, Basen-Engquist K, Huang H, Chan JK, Spirtos NM, Ashfaq R, Mannel RS. Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2017 Jun;18(6):779-91.   PMCID: PMC5715461
Collins BN, Lepore SJ. Babies Living Safe & Smokefree: randomized controlled trial of a multilevel multimodal behavioral intervention to reduce low-income children's tobacco smoke exposure. BMC public health. 2017 Mar 14;17(1):249.   PMCID: PMC5348842
Darlow SD, Heckman CJ, Munshi T, Collins BN. Thirdhand smoke beliefs and behaviors among healthcare professionals. Psychol Health Med. 2017 Apr;22(4):415-24.   PMCID: PMC5659263
Edelman MJ, Wang X, Hodgson L, Cheney RT, Baggstrom MQ, Thomas SP, Gajra A, Bertino E, Reckamp KL, Molina J, Schiller JH, Mitchell-Richards K, Friedman PN, Ritter J, Milne G, Hahn OM, Stinchcombe TE, Vokes EE. Phase III Randomized, placebo-controlled, double-blind trial of celecoxib in addition to standard chemotherapy for advanced non-small-cell lung cancer with cyclooxygenase-2 overexpression: CALGB 30801 (Alliance). Journal of Clinical Oncology. 2017 Jul;35(19):2184-92.   PMCID: PMC5493050
Epperla N, Maddocks KJ, Salhab M, Chavez JC, Reddy N, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn M, Calzada O, Xavier AC, Zhou Z, Hossain NM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Barta SK, Chhabra S, Lansigan F, Mehta A, Jaglal MV, Evans A, Flowers CR, Cohen JB, Fenske TS, Hamadani M, Costa LJ. C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy. Cancer. 2017 Nov 15;123(22):4411-8.
Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SS, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT, Gillison ML. Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer. J Clin Oncol. 2017 Dec 20;35(36):4057-65.   PMCID: PMC5736236
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Female

Female Middle Aged Adult Male Aged Adolescent Young Adult 80 and over Aged pathology Disease-Free Survival genetics therapeutic use administration & dosage therapy surgery adverse effects mortality Antineoplastic Combined Chemotherapy Protocols drug therapy Retrospective Studies Survival Rate metabolism Kaplan-Meier Estimate Prevention Breast Neoplasms Local Neoplasm Recurrence etiology Mothers Intraductal Carcinoma-Noninfiltrating Registries Human papillomavirus diagnostic imaging radiotherapy diagnosis Carboplatin Cancer Preschool Child Tobacco Smoke Pollution Healthcare Disparities Mice enzymology Dendritic Cells Predictive Value of Tests Infant Prognosis Neoplasm Staging methods Vaccine Cohort Studies Inbred C57BL Mice ethnology Chemoradiotherapy Segmental Mastectomy statistics & numerical data Radiation Injuries antagonists & inhibitors Thyroid Diseases Asian Americans Needs Assessment Granulocyte-Macrophage Colony-Stimulating Factor Ovarian Neoplasms Tobacco Cyclooxygenase 2 Inhibitors Cancer Care Facilities Pyrazines Receptor Protein-Tyrosine Kinases Philippines Ductal Carcinoma-Breast Filipino X-Ray Computed Tomography BRCA 2 protein Lung Neoplasms Social Welfare Flow Cytometry Lobular Carcinoma Mutation Organs at Risk basic helix-loop-helix (MYC) Small Cell Carcinoma Melanoma Cyclooxygenase 2 Smoking Cessation Environmental Exposure Health Behavior Toll-Like Receptors Wic epidemiology Survival Analysis Oropharyngeal Neoplasms carcinogen Exercise attitudes Cysts radiation therapy smoke exposure Tobacco Use Disorder Community health Dietary behaviors Toll-Like Receptor 4 Medicaid Interleukin-12 Maternal behavior Hbme1 non-Hodgkin lymphoma Fallopian Tube Neoplasms Tennessee Healthy lifestyle Transcriptome Attitudes Health Knowledge-Practice CD138 SEER Program Health Services Accessibility Cyst Salvage Therapy Proportional Hazards Models Pancreatic Neoplasms Hematopoietic Stem Cell Transplantation Incidence Tumor Biomarkers Lupus Nephritis Animal Disease Models Dinoprostone breast cancer Counseling Diet Parathyroid Glands Follow-Up Studies Randomized Controlled Trials as Topic Fibrosis Paclitaxel Celecoxib Intensity-Modulated Radiotherapy Prospective Studies Radiation Oncology biosynthesis Insurance Coverage Treatment Outcome drug effects cytology Cultured Cells BRCA1 protein Estradiol myc Genes Health Status Disparities physiopathology Thyroid Oral Administration Bevacizumab Double-Blind Method Health Services Needs and Demand
Last updated on Tuesday, December 04, 2018